Effects of nebulaized gentamycin in COPD
Not Applicable
- Conditions
- Chronic Obsructive Pulmonary Disease.Choronic Obstructive Pulmonary Diseases
- Registration Number
- IRCT2015081723659N1
- Lead Sponsor
- Vice chancellor for research, Shahrekord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 82
Inclusion Criteria
absence of renal failure; lack of sensitivity to gentamicin; no cancer; no bronchiectasis; no heart disease; grade 1, 2 and 3
Exclusion criteria: heart disease; kidney failure; cancer; bronchiectasis; pulmonary infection; other; sensitivity to gentamicin; Grid 4.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method O2sat. Timepoint: Before and after the intervention. Method of measurement: Pulse Oximetery.;Lung volumes and capacity. Timepoint: Before and after the intervention. Method of measurement: Spirometry.;White blood cells. Timepoint: Before and after the intervention. Method of measurement: Lab data.
- Secondary Outcome Measures
Name Time Method Dyspnea. Timepoint: Before and after the intervention. Method of measurement: Borg Scale.